Targeting Spermine Oxidase to Mitigate Traumatic Brain Injury Pathology in the Aging Brain
Antioxidants · 11.06.2025 · 14 (6) · 709
DOI: 10.3390/antiox14060709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 11.06.2025. Verfasst von Jui-Ming Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Neurosurgery, Department of Surgery, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chia-Yi City 600, Taiwan. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, Cathay General Hospital.
Abstract (Originalsprache)
Traumatic brain injury (TBI) in the elderly is frequently associated with worsened neurological outcomes and prolonged recovery, yet the age-specific molecular mechanisms driving this vulnerability remain poorly understood. Aging is characterized by increased oxidative stress and chronic neuro-inflammation, both of which may amplify the brain’s susceptibility to injury. In this study, we identify spermine oxidase (SMOX), a polyamine-catabolizing enzyme that produces reactive oxygen species, as a key mediator linking oxidative stress and neuro-inflammation to age-dependent TBI susceptibility. Using a mouse model of controlled cortical impact (CCI), we found that SMOX expression was significantly upregulated in aged brains, primarily in neurons and microglia, and this increase correlated with greater microglial activation, elevated pro-inflammatory cytokine expression, and widespread neuronal degeneration. Notably, SMOX upregulation also impaired astrocytic glutamate clearance by disrupting the membrane localization of the transporter GLT-1, contributing to excitotoxic stress. Importantly, analysis of postmortem human brain samples and transcriptomic data revealed a parallel age-related increase in SMOX expression, supporting its translational relevance. The pharmacological inhibition of SMOX with JNJ-9350 in aged mice reduced oxidative and inflammatory markers, preserved neuronal viability, and improved motor, cognitive, and emotional outcomes up to 30 days post-injury. These findings establish SMOX as a critical molecular driver of age-related vulnerability to TBI and highlight its inhibition as a promising therapeutic strategy for improving outcomes in elderly TBI patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Neurosurgery, Department of Surgery, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chia-Yi City 600, Taiwan.
- Department of Nursing, School of Nursing, Fooyin University, Kaohsiung City 831, Taiwan.
- Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
- Department of Medical Research, Cathay General Hospital, Taipei 106, Taiwan.
- Chung-Jen Junior College of Nursing, Health Sciences and Management, Chia-Yi City 622, Taiwan.
- Division of Neurosurgery, Department of Surgery, Cathay General Hospital, Taipei 106, Taiwan.
ORCID-Profile: Jing-Shiun Jan, Ting-Lin Yen, Chih-Hao Yang
Förderung
- National Science and Technology Council, Taiwan
- Cathay General Hospital
Zitieren
APA
Sun, J. M., Jan, J. S., Yen, T. L., Chen, Y. H., Teng, R. D., Yang, C. H., & Hsieh, C. T. (2025). Targeting Spermine Oxidase to Mitigate Traumatic Brain Injury Pathology in the Aging Brain. Antioxidants, 14(6), 709. https://doi.org/10.3390/antiox14060709
Vancouver
Sun JM, Jan JS, Yen TL, Chen YH, Teng RD, Yang CH, et al. Targeting Spermine Oxidase to Mitigate Traumatic Brain Injury Pathology in the Aging Brain. Antioxidants. 2025;14(6):709. doi:10.3390/antiox14060709
BibTeX
@article{Sun2025,
author = {Sun, Jui-Ming and Jan, Jing-Shiun and Yen, Ting-Lin and Chen, Yu-Hao and Teng, Ruei-Dun and Yang, Chih-Hao and Hsieh, Cheng-Ta},
title = {Targeting Spermine Oxidase to Mitigate Traumatic Brain Injury Pathology in the Aging Brain},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {6},
pages = {709},
doi = {10.3390/antiox14060709}
}
EUVIMED